SAB Biotherapeutics (SABS) PT Lowered to $6 at H.C. Wainwright following Q4 report

April 2, 2024 6:44 AM EDT Send to a Friend
(Updated - April 2, 2024 6:51 AM EDT)

H.C. Wainwright analyst Edward White lowered the price target on SAB ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login